Stockholders' Equity (Details) - USD ($)					1 Months Ended	3 Months Ended
	Oct. 15, 2021	Aug. 13, 2021	Feb. 02, 2021	May 01, 2017	Sep. 15, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Sep. 30, 2021
Stockholders' Equity (Details) [Line Items]
Reverse stock split, description	the Company announced that its shareholders had approved a reverse split of its common stock and Series C Preferred at a ratio of 1 for 10. As a result of the reverse split, every 10 pre-split shares of common stock outstanding and every 10 pre-split shares of Series C Preferred stock outstanding were automatically exchanged for one new share of each without any action on the part of the holders.
Common stock shares outstanding						9,593,378		9,163,039
Common stock, par value (in Dollars per share)						$ 0.0001		$ 0.0001
Gross proceeds (in Dollars)					$ 12,500,000
Warrant term, description		On August 13, 2021, the Company entered into a securities purchase agreement with institutional accredited investors providing for an aggregate investment of $4,000,000 for the issuance by the Company of (i) 1,333,333 shares of Series F Convertible Preferred Stock, par value $0.0001 per share, of the Company (the Series F Preferred Stock) convertible into shares of common stock, par value $0.0001 per share, of the Company that is issuable upon conversion of shares of Series F Preferred Stock; (ii) warrants, with a term of five and a half years exercisable after February 16, 2022, to purchase an aggregate of up to 666,667 shares of Common Stock at an exercise price of $7.80 per share.
Investment (in Dollars)		$ 4,000,000
Preferred stock, par value (in Dollars per share)						$ 0.0001		$ 0.0001
Voting rights, description						One share of Series C Preferred Stock carries the same voting rights as one share of common stock.
Maximum [Member]
Stockholders' Equity (Details) [Line Items]
Common stock shares outstanding	88,300,000
Minimum [Member]
Stockholders' Equity (Details) [Line Items]
Common stock shares outstanding	8,800,000
Series C Preferred Stock [Member]
Stockholders' Equity (Details) [Line Items]
Preference stock shares outstanding						200		200
Preferred stock, par value (in Dollars per share)						$ 0.0001		$ 0.0001
Cumulative dividends rate				15.00%
Preferred stock dividends (in Dollars)						$ 75,000	$ 75,000
Series C Preferred Stock [Member] | Maximum [Member]
Stockholders' Equity (Details) [Line Items]
Preference stock shares outstanding	2,000
Series C Preferred Stock [Member] | Minimum [Member]
Stockholders' Equity (Details) [Line Items]
Preference stock shares outstanding	200
September 2021 Offering [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate of sale, shares					2,788,750
Common stock, par value (in Dollars per share)					$ 0.0001
Aggregate of purchase shares					2,788,750
Exercise price per share (in Dollars per share)					$ 4.95
Additional shares of common stock					363,750
Warrant exercise price (in Dollars per share)	$ 3.956
August 2021 Offering [Member]
Stockholders' Equity (Details) [Line Items]
Common stock, par value (in Dollars per share)		$ 0.0001
Shares issued		1,333,333
Preferred stock, par value (in Dollars per share)		$ 0.0001
Common stock, shares issued		666,667							656,604
Common stock exercise price per share (in Dollars per share)		$ 7.8
Preferred stock, shares issued									1,160,000
Warrants per share (in Dollars per share)	$ 4.95
July 2020 Offerings [Member]
Stockholders' Equity (Details) [Line Items]
Registered direct offering, description			(i) an aggregate of 1,476,016 shares of Series E preferred stock, convertible into up to 295,203 shares of common stock, (ii) common stock purchase warrants to purchase up to 100,000 shares of common stock at an exercise price of $12.30 per share, which were exercisable immediately and had a term of five years, and (iii) common stock purchase warrants to purchase up to 195,203 shares of common stock at an exercise price of $12.30 per share with a term of five and one-half years first exercisable nine months after issuance, for gross proceeds of $4,000,003, before deducting any offering expenses. The Company used the net proceeds from this offering for working capital and liability reduction purposes. In February 2021, 1,476,016 shares of Series E preferred stock were converted into 295,203 shares of common stock. Also in February 2021, the Company recorded a deemed dividend of $1,480,801 from the beneficial conversion feature associated with the issuance of the Series E convertible preferred stock and warrants.
January 2021 Warrant exchange [Member]
Stockholders' Equity (Details) [Line Items]
Common stock, shares issued						246,913
Common stock exercise price per share (in Dollars per share)						$ 15.25
Warrants						50,000
January 2021 Warrant exchange [Member] | Warrant [Member]
Stockholders' Equity (Details) [Line Items]
Warrants						50,000